US Patent Issued to University of Washington, THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY on Feb. 18 for "De novo design of potent and selective interleukin mimetics" (Washington Inventors)

ALEXANDRIA, Va., Feb. 19 -- United States Patent no. 12,227,553, issued on Feb. 18, was assigned to University of Washington (Seattle) and THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (Stanford, Calif.).

"De novo design of potent and selective interleukin mimetics" was invented by Daniel Adriano Silva Manzano (Seattle), Shawn Yu (Seattle), Umut Ulge (Seattle), David Baker (Seattle), Kenan Christopher Garcia (Seattle), Jamie Spangler (Seattle) and Carl Walkey (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "De novo designed polypeptides that bind to IL-2 receptor BetaGammac heterodimer (IL-2RBetaGammac), IL-4 receptor AlphaGammac heterodimer (IL-4RAlphaGammac), or IL-13 receptor Alpha...